The trajectory of Sildenafil presents a complex case for investors in the medicinal sector. While initially a blockbuster success, generating huge profits, the patent expiration and the subsequent arrival of generic https://pharma314796.amoblog.com/sildenafil-and-pharma-a-hazardous-play-63884103